Genetic Technologies Sues 10 Firms for Infringement on a Method to Determine Haplotype | GenomeWeb

This story has been updated from a previous version posted May 26 to include information from the court documents.

Australian genetic testing company Genetic Technologies has sued 10 firms, including 454 Life Sciences, for infringing a patent it holds on method to determine haplotype information from non-coding DNA.

The other firms named in the suit, which was filed this week in the US District Court for the District of Colorado, are Agilent, Bristol-Myers Squibb, Eurofins, GlaxoSmithKline, Hologic, Merial, Navigenics, Neogen, and Pfizer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.